Sonoma Pharmaceuticals Inc
(SNOA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Sales | 13,854 | 13,668 | 15,452 | 12,744 | 9,754 |
| Cost of Goods | 6,566 | 5,271 | 4,709 | 4,030 | 3,613 |
| Gross Profit | 7,288 | 8,397 | 10,743 | 8,714 | 6,141 |
| Operating Expenses | 14,513 | 14,719 | 14,826 | 15,211 | 14,259 |
| Operating Income | -6,659 | -6,051 | -3,374 | -6,467 | -7,505 |
| Interest Expense | 3 | 1,058 | 1,107 | 931 | 406 |
| Other Income | -1,541 | 10,844 | -950 | 69 | -37 |
| Pre-tax Income | -8,203 | 3,735 | -5,431 | -7,329 | -7,948 |
| Net Income Continuous | -8,203 | 3,735 | -5,431 | -7,329 | -7,948 |
| Net Income | $-8,203 | $3,735 | $-5,431 | $-7,329 | $-7,948 |
| EPS Basic Total Ops | -765.08 | 486.05 | -1,170.12 | -1,683.17 | -1,889.62 |
| EPS Basic Continuous Ops | -764.57 | 488.50 | -982.20 | -1,686.29 | -1,898.17 |
| EPS Diluted Total Ops | -765.08 | 486.05 | -1,170.12 | -1,683.17 | -1,889.62 |
| EPS Diluted Continuous Ops | -764.57 | 487.36 | -982.20 | -1,686.29 | -1,898.17 |
| EBITDA(a) | $-6,406 | $-5,767 | $-3,106 | $-6,141 | $-7,110 |